Chipiron Full-Body ULF MRI Scanner
Cancer screening, early diagnosis, image-guided therapy; broad diagnostic imaging
Pre-clinicalActive Development
Key Facts
Indication
Cancer screening, early diagnosis, image-guided therapy; broad diagnostic imaging
Phase
Pre-clinical
Status
Active Development
Company
About Chipiron
Chipiron is a pioneering medtech startup building a disruptive, ultra-low-field (<10 mT) full-body MRI scanner designed to be lightweight, affordable, and operable without shielded rooms or specialized technicians. The company has secured significant non-dilutive grants and equity financing, including a $17M Series A and a major EIC Accelerator award, validating its ambitious vision. With a roadmap targeting first in-vivo images in 2025 and FDA clearance in 2028, Chipiron aims to revolutionize medical imaging by making MRI screening and image-guided therapies accessible on a global scale.
View full company profile